Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » EU reaches political agreement on pharma package

    EU reaches political agreement on pharma package

    eub2eub211 December 2025Updated:14 December 2025 Health
    — Filed under: EU News
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The EU’s Council and Parliament have reached agreement on major reform of EU pharmaceutical rules, to increase patients’ access to medicine and make the EU’s pharmaceutical sector fairer and more competitive.

    Pharmaceuticals - Photo by Laurynas Me on Unsplash

    “The deal demonstrates the EU’s commitment to both innovation and to ensuring that patients in Europe have access to the medicines they need,” said Denmark’s minister for health Sophie Løhde, for the EU presidency: “We are strengthening incentives for priority antibiotics, reducing red tape for the life science industry, and safeguarding the availability of essential medicines.”

    The deal also seeks to boost the competitiveness of the pharmaceutical industry by cutting regulatory burdens and strengthening security of supply to prevent and manage shortages.

    Under the text agreed by the co-legislators, companies placing a new medicine on the market benefit from an eight-year data protection period, meaning they have exclusive rights to data from pre-clinical tests and clinical trials.

    They will also benefit from one year of market protection (the exclusive right to sell a product without immediate competition from generic medicines or biosimilars), which may be extended by an additional year for innovative medicines that satisfy two out of three conditions.

    To ensure the availability of key medicines, the co-legislators have kept a provision introduced by the Council (article 56a) giving EU countries the power to require companies to supply medicines benefiting from regulatory protection in sufficient quantities to meet patient needs.

    Following negotiations, safeguards have been added to the text clarifying obligations for companies and member states, and preventing the use of article 56a as an opportunity for parallel trade.

    The pharma package includes an intellectual property exemption allowing manufacturers to take the necessary steps (such as studies or trials) to ensure that generic versions of a medicine can be made available on day one after the intellectual property rights have expired.

    The co-legislators have clarified the wording of this provision, and have maintained the Council’s extension of the scope to include submissions for procurement tenders.

    The pharma package introduces a new transferrable exclusivity voucher incentivising pharmaceutical companies to help combat antimicrobial resistance by developing priority antibiotics.

    Under the agreement reached between the Council and the Parliament, this voucher will grant companies one additional year of market protection for a pharmaceutical product of their choice.

    The Parliament has also agreed to maintain the Council’s proposed ‘blockbuster clause’, which limits the potential impact on national healthcare budgets by stipulating that the transferrable voucher cannot be used on products with annual gross sales of more than €490 million in the preceding four years.

    The ‘pharma package’: new EU rules on medicines explained (background information)

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    eub2
    • Website

    eub2 is the default publisher for EUbusiness.

    Related Content

    Running - Image by Th G from Pixabay

    EU sets out vision for sport in Europe

    AIM logo

    Project Manager, International Association of Mutual Benefit Societies, AIM

    ESIP - European Social Insurance Platform logo

    Policy Officer in Healthcare, European Social Insurance Platform, ESIP

    Access VetMed logo

    Public Affairs Advisor, Access VetMed

    Wine bottles - Photo by CHUTTERSNAP on Unsplash

    5 pct of Europeans consumed alcohol daily in 2025

    Health screening - Image © European Union 2026

    Brussels launches EU Screening Week

    LATEST EU NEWS
    Wrapping plastics packaging - Photo by Léster Lau on Pexels

    Rules prohibiting EU exports of plastic waste to non-OECD countries enter into force

    20 November 2026
    UK-EU-Ursula von der Leyen, Andy Burnham, António Costa - Photo © European Union 2026

    Brexit reset underway as UK’s deal with EU offers new opportunities for young people

    20 November 2026
    Oil tanker - Image by Erich Westendarp from Pixabay

    EU to delay methane reporting and monitoring for energy importers

    19 November 2026
    AI - Artificial Intelligence - Image by Gerd Altmann from Pixabay

    EU calls on states to equip citizens for the age of AI

    19 November 2026
    Euro - ECB-Photo by Mika Baumeister on Unsplash

    November currency outlook – Euro currency news

    19 November 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}
    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?